The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition
Véronique Michaud(Research & Development Institute), Mark A. Wainberg(Jewish General Hospital), Tamara Bar-Magen(Jewish General Hospital), Jacques Turgeon(Académie Nationale de Médecine), Zeruesenay Desta(Jewish General Hospital), David A. Flockhart(Indiana University – Purdue University Indianapolis)
Cited by 107
Related Papers
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response
|Clinical Pharmacology & Therapeutics|2007|243
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
|Pharmaceutics|2020|237
Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
|Annals of Pharmacotherapy|2013|186